BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hammond SP, Marty FM, Bryar JM, DeAngelo DJ, Baden LR. Invasive fungal disease in patients treated for newly diagnosed acute leukemia. Am J Hematol. 2010;85:695-699. [PMID: 20652970 DOI: 10.1002/ajh.21776] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Das A, Oberoi S, Trehan A, Chakrabarti A, Bansal D, Saxena AK, Sodhi KS, Kakkar N, Srinivasan R. Invasive Fungal Disease in Pediatric Acute Leukemia in the Nontransplant Setting: 8 Years' Experience From a Tertiary Care Center in North India. J Pediatr Hematol Oncol 2018;40:462-7. [PMID: 29189511 DOI: 10.1097/MPH.0000000000001027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Lupiañez CB, Canet LM, Carvalho A, Alcazar-Fuoli L, Springer J, Lackner M, Segura-Catena J, Comino A, Olmedo C, Ríos R, Fernández-Montoya A, Cuenca-Estrella M, Solano C, López-Nevot MÁ, Cunha C, Oliveira-Coelho A, Villaescusa T, Fianchi L, Aguado JM, Pagano L, López-Fernández E, Potenza L, Luppi M, Lass-Flörl C, Loeffler J, Einsele H, Vazquez L, Jurado M, Sainz J; PCRAGA Study Group. Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium. Infect Immun 2015;84:643-57. [PMID: 26667837 DOI: 10.1128/IAI.01359-15] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
3 Ishihara Y, Kimura S, Akahoshi Y, Harada N, Nakano H, Kameda K, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kikuchi M, Nakasone H, Yamazaki R, Kanda J, Kako S, Tanihara A, Nishida J, Usuki K, Kanda Y. Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma. Hematology 2016;21:19-25. [PMID: 26352559 DOI: 10.1179/1607845415Y.0000000051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Kumar M, Mugunthan M. β-d-Glucan and Aspergillus Galactomannan assays in the diagnosis of invasive fungal infections. Med J Armed Forces India 2019;75:357-60. [PMID: 31719727 DOI: 10.1016/j.mjafi.2017.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Heath JL, Yin DE, Wechsler DS, Turner DA. Successful treatment of disseminated cryptococcal infection in a pediatric acute lymphoblastic leukemia patient during induction. J Pediatr Hematol Oncol 2012;34:e161-3. [PMID: 22258349 DOI: 10.1097/MPH.0b013e318236c502] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Handous I, Achour B, Marzouk M, Rouis S, Hazgui O, Brini I, Khelif A, Hannachi N, Boukadida J. Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy. Virol J 2020;17:37. [PMID: 32183884 DOI: 10.1186/s12985-020-01302-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
7 Park H, Youk J, Shin DY, Hong J, Kim I, Kim NJ, Lee JO, Bang SM, Yoon SS, Park WB, Koh Y. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy. BMC Cancer 2019;19:358. [PMID: 30991992 DOI: 10.1186/s12885-019-5557-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
8 Hansen BA, Wendelbo Ø, Bruserud Ø, Hemsing AL, Mosevoll KA, Reikvam H. Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment. Mediterr J Hematol Infect Dis 2020;12:e2020009. [PMID: 31934319 DOI: 10.4084/MJHID.2020.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
9 Bhimji A, Bhaskaran A, Singer LG, Kumar D, Humar A, Pavan R, Lipton J, Kuruvilla J, Schuh A, Yee K, Minden MD, Schimmer A, Rotstein C, Keshavjee S, Mazzulli T, Husain S. Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients. Clin Microbiol Infect 2018;24:640-5. [PMID: 28970160 DOI: 10.1016/j.cmi.2017.09.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
10 Scott-thomas A, Chambers ST. Volatile Organic Compounds: Upcoming Role in Diagnosis of Invasive Mould Infections. Curr Fungal Infect Rep 2017;11:117-23. [DOI: 10.1007/s12281-017-0284-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tang JL, Kung HC, Lei WC, Yao M, Wu UI, Hsu SC, Lin CT, Li CC, Wu SJ, Hou HA, Chou WC, Huang SY, Tsay W, Chen YC, Chen YC, Chang SC, Ko BS, Tien HF. High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan. PLoS One 2015;10:e0128410. [PMID: 26061179 DOI: 10.1371/journal.pone.0128410] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
12 Özdemir N, Tüysüz G, Çelik N, Yantri L, Erginöz E, Apak H, Özkan A, Yıldız İ, Celkan T. Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience. Turk Pediatri Ars 2016;51:79-86. [PMID: 27489464 DOI: 10.5152/TurkPediatriArs.2016.2757] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
13 Phoompoung P, Henry B, Daher-Reyes G, Sibai H, Husain S. Invasive Mold Infections in FLT3-Mutated Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk 2021;21:e477-82. [PMID: 33678591 DOI: 10.1016/j.clml.2020.10.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Letourneau AR, Issa NC, Baden LR. Pneumonia in the immunocompromised host. Curr Opin Pulm Med 2014;20:272-9. [PMID: 24626236 DOI: 10.1097/MCP.0000000000000051] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
15 Neofytos D, Lu K, Hatfield-Seung A, Blackford A, Marr KA, Treadway S, Ostrander D, Nussenblatt V, Karp J. Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy. Diagn Microbiol Infect Dis 2013;75:144-9. [PMID: 23142166 DOI: 10.1016/j.diagmicrobio.2012.10.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 5.7] [Reference Citation Analysis]
16 Candoni A, Farina F, Perruccio K, Di Blasi R, Criscuolo M, Cattaneo C, Delia M, Zannier ME, Dragonetti G, Fanci R, Martino B, Del Principe MI, Fianchi L, Vianelli N, Chierichini A, Garzia M, Petruzzellis G, Nadali G, Verga L, Busca A, Pagano L. Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study). Mycoses 2020;63:1094-100. [PMID: 32697010 DOI: 10.1111/myc.13147] [Reference Citation Analysis]
17 Hsu A, Matera R, Vieira K, Reagan JL, Farmakiotis D. Antifungal prophylaxis during 7 + 3 induction chemotherapy for acute myeloid leukemia is associated with improved survival, in a setting with low incidence of invasive mold infections. Support Care Cancer 2021;29:707-12. [PMID: 32435969 DOI: 10.1007/s00520-020-05535-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Epstein DJ, Seo SK, Brown JM, Papanicolaou GA. Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies. J Antimicrob Chemother 2018;73:i60-72. [PMID: 29304213 DOI: 10.1093/jac/dkx450] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
19 Mulanovich VE, Kontoyiannis DP. Fungal pneumonia in patients with hematologic malignancies: current approach and management. Curr Opin Infect Dis 2011;24:323-32. [PMID: 21666457 DOI: 10.1097/QCO.0b013e3283486d1d] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
20 Kimura S, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Yamasaki R, Ashizawa M, Machishima T, Sato M, Terasako K, Nakasone H, Kikuchi M, Okuda S, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y. D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine. Hematology 2014;19:107-12. [PMID: 23683842 DOI: 10.1179/1607845413Y.0000000103] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Mehta D, Hofacker SA, Villalba JA, Duncan LM, Branda JA, Cañete-Gibas C, Wiederhold N, Moran J, Fathi AT, Chen ST, Cervantes J, Hammond SP. First Reported Case of Invasive Cutaneous Penicillium cluniae Infection in a Patient With Acute Myelogenous Leukemia: A Case Report and Literature Review. Open Forum Infect Dis 2021;8:ofab265. [PMID: 34258314 DOI: 10.1093/ofid/ofab265] [Reference Citation Analysis]
22 Valentine JC, Morrissey CO, Tacey MA, Liew D, Patil S, Peleg AY, Ananda-Rajah MR. A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005 - 2016. BMC Infect Dis 2019;19:274. [PMID: 30898090 DOI: 10.1186/s12879-019-3901-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
23 Feng Y, Guo W, Wang Y, Shi W, Liu C, Li D, Qiu Y, Shi D. Rhinocerebral mucormycosis caused by Rhizopus oryzae in a patient with acute myeloid leukemia: A case report. WJD 2020;8:1-9. [DOI: 10.5314/wjd.v8.i1.1] [Reference Citation Analysis]
24 Vedula RS, Cheng MP, Ronayne CE, Farmakiotis D, Ho VT, Koo S, Marty FM, Lindsley RC, Bold TD. Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease. Blood Adv 2021;5:54-60. [PMID: 33570623 DOI: 10.1182/bloodadvances.2020002854] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Abdul-Hamil NA, Wong GC, Nagarajan C, Martinelli G, Cherchione C. Midostaurin in acute myeloid leukemia: current evidence and practical considerations in routine clinical use. Minerva Med 2020;111:443-54. [PMID: 32955824 DOI: 10.23736/S0026-4806.20.07014-7] [Reference Citation Analysis]
26 Koo S, Thomas HR, Daniels SD, Lynch RC, Fortier SM, Shea MM, Rearden P, Comolli JC, Baden LR, Marty FM. A breath fungal secondary metabolite signature to diagnose invasive aspergillosis. Clin Infect Dis 2014;59:1733-40. [PMID: 25342502 DOI: 10.1093/cid/ciu725] [Cited by in Crossref: 95] [Cited by in F6Publishing: 74] [Article Influence: 13.6] [Reference Citation Analysis]
27 Mariette C, Tavernier E, Hocquet D, Huynh A, Isnard F, Legrand F, Lhéritier V, Raffoux E, Dombret H, Ifrah N, Cahn J, Thiébaut A. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study. Leukemia & Lymphoma 2016;58:586-93. [DOI: 10.1080/10428194.2016.1204652] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
28 Pham AN, Bubalo JS, Lewis JS 2nd. Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections. Mycoses 2016;59:226-33. [PMID: 26742659 DOI: 10.1111/myc.12452] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
29 Hardak E, Fuchs E, Geffen Y, Zuckerman T, Oren I. Clinical Spectrum, Diagnosis and Outcome of Rare Fungal Infections in Patients with Hematological Malignancies: Experience of 15-Year Period from a Single Tertiary Medical Center. Mycopathologia. 2020;185:347-355. [PMID: 32100219 DOI: 10.1007/s11046-020-00436-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lien MY, Chou CH, Lin CC, Bai LY, Chiu CF, Yeh SP, Ho MW. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study. PLoS One 2018;13:e0197851. [PMID: 29883443 DOI: 10.1371/journal.pone.0197851] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
31 Korula A, Abraham A, Abubacker FN, Viswabandya A, Lakshmi KM, Abraham OC, Rupali P, Varghese GM, Michael JS, Srivastava A, Mathews V, George B. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country. Mycoses 2017;60:686-91. [PMID: 28736936 DOI: 10.1111/myc.12646] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
32 Fischer M, Müller JP, Spies-Weisshart B, Gräfe C, Kurzai O, Hünniger K, Hochhaus A, Scholl S, Schnetzke U. Isoform localization of Dectin-1 regulates the signaling quality of anti-fungal immunity. Eur J Immunol 2017;47:848-59. [PMID: 28303575 DOI: 10.1002/eji.201646849] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
33 Liu YC, Zhou ML, Cheng KJ, Zhou SH, Wen X, Chang CD. Successful treatment of invasive fungal rhinosinusitis caused by Cunninghamella: A case report and review of the literature. World J Clin Cases 2019;7:228-35. [PMID: 30705900 DOI: 10.12998/wjcc.v7.i2.228] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
34 Auberger J, Lass-florl C, Aigner M, Clausen J, Gastl G, Nachbaur D. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. Journal of Antimicrobial Chemotherapy 2012;67:2268-73. [DOI: 10.1093/jac/dks189] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 11.1] [Reference Citation Analysis]
35 Gupta A, Damania RC, Talati R, O'Riordan MA, Matloub YH, Ahuja SP. Increased Toxicity Among Adolescents and Young Adults Compared with Children Hospitalized with Acute Lymphoblastic Leukemia at Children's Hospitals in the United States. J Adolesc Young Adult Oncol 2021. [PMID: 33512257 DOI: 10.1089/jayao.2020.0154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Singh S, Kaur H, Choudhary H, Sethi S, Malhotra P, Gupta KL, Rudramurthy SM, Chakrabarti A. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre. Indian J Med Microbiol 2018;36:557-63. [PMID: 30880706 DOI: 10.4103/ijmm.IJMM_18_366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Bhatt VR, Viola GM, Ferrajoli A. Invasive fungal infections in acute leukemia. Ther Adv Hematol 2011;2:231-47. [PMID: 23556092 DOI: 10.1177/2040620711410098] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
38 Nganthavee V, Phutthasakda W, Atipas K, Tanpong S, Pungprasert T, Dhirachaikulpanich D, Krithin S, Tanglitanon S, Jutidamronphang W, Owattanapanich W, Chayakulkeeree M, Phikulsod P. High incidence of invasive fungal infection during acute myeloid leukemia treatment in a resource-limited country: clinical risk factors and treatment outcomes. Support Care Cancer 2019;27:3613-22. [PMID: 31165931 DOI: 10.1007/s00520-019-04720-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]